T0	Participants 30 61	chronic immune thrombocytopenia
T1	Participants 292 337	patients with chronic immune thrombocytopenia
T2	Participants 437 582	adults with previously treated immune thrombocytopenia of more than 6 months' duration who had baseline platelet counts lower than 30,000 per Î¼L.
T3	Participants 948 954	status
T4	Participants 1458 1520	FINDINGS Between Nov 22, 2006, and July 31, 2007, 197 patients
T5	Participants 2845 2918	beneficial for patients who have not responded to splenectomy or previous